These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38816349)

  • 1. HAS2 facilitates glioma cell malignancy and suppresses ferroptosis in an FZD7-dependent manner.
    Liu Z; Yu K; Chen K; Liu J; Dai K; Zhao P
    Cancer Sci; 2024 Aug; 115(8):2602-2616. PubMed ID: 38816349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of HAS2 promotes glioma cell proliferation and chemoresistance via c-myc.
    Wang J; Ruan S; Yu T; Meng X; Ran J; Cen C; Kong C; Bao X; Li Z; Wang Y; Ren M; Guo P; Teng Y; Zhang D
    Cell Signal; 2024 Aug; 120():111218. PubMed ID: 38734194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway.
    Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y
    J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transcription factor USF1 promotes glioma cell invasion and migration by activating lncRNA HAS2-AS1.
    Wang J; Gu J; You A; Li J; Zhang Y; Rao G; Ge X; Zhang K; Li J; Liu X; Wang Q; Lin T; Cheng L; Zhu M; Wu X; Wang D
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. hsa_circ_0000177-miR-638-FZD7-Wnt Signaling Cascade Contributes to the Malignant Behaviors in Glioma.
    Chen Z; Duan X
    DNA Cell Biol; 2018 Sep; 37(9):791-797. PubMed ID: 30010402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frizzled-7 Identifies Platinum-Tolerant Ovarian Cancer Cells Susceptible to Ferroptosis.
    Wang Y; Zhao G; Condello S; Huang H; Cardenas H; Tanner EJ; Wei J; Ji Y; Li J; Tan Y; Davuluri RV; Peter ME; Cheng JX; Matei D
    Cancer Res; 2021 Jan; 81(2):384-399. PubMed ID: 33172933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HAS2-AS1 Acts as a Molecular Sponge for miR-137 and Promotes the Invasion and Migration of Glioma Cells by Targeting EZH2.
    Wang J; Zhang Y; You A; Li J; Gu J; Rao G; Ge X; Zhang K; Fu H; Liu X; Li J; Wang Q; Wu X; Cheng L; Zhu M; Wang D
    Cell Cycle; 2020 Nov; 19(21):2826-2835. PubMed ID: 33064966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid synthase 2 promotes malignant phenotypes of colorectal cancer cells through transforming growth factor beta signaling.
    Kim YH; Lee SB; Shim S; Kim A; Park JH; Jang WS; Lee SJ; Myung JK; Park S; Lee SJ; Kim MJ
    Cancer Sci; 2019 Jul; 110(7):2226-2236. PubMed ID: 31102316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer.
    Yu M; Zhang K; Wang S; Xue L; Chen Z; Feng N; Ning C; Wang L; Li J; Zhang B; Yang C; Zhang Z
    Biomed Res Int; 2021; 2021():8861766. PubMed ID: 33506044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of FZD7 promotes glioma cell proliferation by upregulating TAZ.
    Qiu X; Jiao J; Li Y; Tian T
    Oncotarget; 2016 Dec; 7(52):85987-85999. PubMed ID: 27852064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircCDK14 Promotes Tumor Progression and Resists Ferroptosis in Glioma by Regulating PDGFRA.
    Chen S; Zhang Z; Zhang B; Huang Q; Liu Y; Qiu Y; Long X; Wu M; Zhang Z
    Int J Biol Sci; 2022; 18(2):841-857. PubMed ID: 35002529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GNA14 stimulation of KLF7 promotes malignant growth of endometrial cancer through upregulation of HAS2.
    Wang J; Teng F; Chai H; Zhang C; Liang X; Yang Y
    BMC Cancer; 2021 Apr; 21(1):456. PubMed ID: 33892667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a ferroptosis-related prognostic signature and validation of ITGA6-AS1 in enhancing cell proliferation, migration and invasion in glioma.
    Jiang M; Liu Y; Zhang T; Ye G; Hong S; Qi Z
    Int Immunopharmacol; 2024 Aug; 137():112438. PubMed ID: 38875999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
    Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
    Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-504 functions as a tumor suppressor in hepatocellular carcinoma through inhibiting Frizzled-7-mediated-Wnt/β-catenin signaling.
    Quan H; Li B; Yang J
    Biomed Pharmacother; 2018 Nov; 107():754-762. PubMed ID: 30142536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of SFRP2 facilitates cancer stemness and radioresistance of glioma cells via activating Wnt/β-catenin signaling.
    Wu Q; Yin X; Zhao W; Xu W; Chen L
    PLoS One; 2021; 16(12):e0260864. PubMed ID: 34852024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Orphan nuclear receptor TLX promotes immunosuppression via its transcriptional activation of PD-L1 in glioma.
    Zhou J; Pei X; Yang Y; Wang Z; Gao W; Ye R; Zhang X; Liu J; Liu Z; Yang X; Tao J; Gu C; Hu W; Chan FL; Li X; Mao J; Wu D
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33858847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronan synthase 2 (HAS2) regulates cell phenotype and invadopodia formation in luminal-like breast cancer cells.
    Sheng Y; Cao M; Liu Y; He Y; Zhang G; Du Y; Gao F; Yang C
    Mol Cell Biochem; 2021 Sep; 476(9):3383-3391. PubMed ID: 33954907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural antisense transcript HAS2-AS1 regulates breast cancer cells aggressiveness independently from hyaluronan metabolism.
    Parnigoni A; Caon I; Teo WX; Hua SH; Moretto P; Bartolini B; Viola M; Karousou E; Yip GW; Götte M; Heldin P; Passi A; Vigetti D
    Matrix Biol; 2022 May; 109():140-161. PubMed ID: 35395387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.